Radiomics and AI-Based Prediction of MGMT Methylation Status in Glioblastoma Using Multiparametric MRI: A Hybrid Feature Weighting Approach
<b>Background/Objectives</b>: Glioblastoma (GBM) is a highly aggressive primary central nervous system tumor with a median survival of 14 months. MGMT (O6-methylguanine-DNA methyltransferase) promoter methylation status is a key biomarker as a prognostic indicator and a predictor of chem...
Saved in:
| Main Authors: | Erdal Tasci, Ying Zhuge, Longze Zhang, Holly Ning, Jason Y. Cheng, Robert W. Miller, Kevin Camphausen, Andra V. Krauze |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-05-01
|
| Series: | Diagnostics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2075-4418/15/10/1292 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Radiomics prediction of MGMT promoter methylation in adult diffuse gliomas: a combination of structural MRI, DCE, and DTI
by: Yuying Liu, et al.
Published: (2025-01-01) -
Prediction of MGMT methylation status in glioblastoma patients based on radiomics feature extracted from intratumoral and peritumoral MRI imaging
by: Wang-Sheng Chen, et al.
Published: (2025-07-01) -
The TERT promoter mutation status and MGMT promoter methylation status, combined with dichotomized MRI‐derived and clinical features, predict adult primary glioblastoma survival
by: Chang Shu, et al.
Published: (2018-08-01) -
IDH mutation and MGMT methylation status in glioblastoma and other gliomas patients: a Russian retrospective cohort study
by: Moez Eid, et al.
Published: (2025-05-01) -
The impact of the subventricular zone invasion types and MGMT methylation status on tumor recurrence and prognosis in glioblastoma
by: Zhiying Shao, et al.
Published: (2024-12-01)